Iptakalim Hydrochloride
CAS No. 642407-63-4
Iptakalim Hydrochloride ( —— )
产品货号. M27888 CAS No. 642407-63-4
Iptakalim 是一种亲脂性对氨基化合物,是一种新型 ATP 敏感钾通道 (KATP) 开放剂,也是一种含有 α4β2 的烟碱乙酰胆碱受体 (nAChR) 拮抗剂。
纯度: >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| 规格 | 价格/人民币 | 库存 | 数量 |
| 5MG | ¥469 | 有现货 |
|
| 10MG | ¥718 | 有现货 |
|
| 25MG | ¥1410 | 有现货 |
|
| 50MG | ¥2275 | 有现货 |
|
| 100MG | ¥3306 | 有现货 |
|
| 500MG | 获取报价 | 有现货 |
|
| 1G | 获取报价 | 有现货 |
|
| 1 mL x 10 mM in DMSO | ¥377 | 有现货 |
|
生物学信息
-
产品名称Iptakalim Hydrochloride
-
注意事项本公司产品仅用于科研实验,不得用于人体或动物的临床与诊断
-
产品简述Iptakalim 是一种亲脂性对氨基化合物,是一种新型 ATP 敏感钾通道 (KATP) 开放剂,也是一种含有 α4β2 的烟碱乙酰胆碱受体 (nAChR) 拮抗剂。
-
产品描述Iptakalim, a lipophilic para-amino compound, is a novel ATP-sensitive potassium channel (KATP) opener, as well as an α4β2-containing nicotinic acetylcholine receptor (nAChR) antagonist. Iptakalim is also a K(ir) 6.1/SUR2B activator that can attenuate hypoxia-induced pulmonary arterial hypertension in rats by endothelial function protection.
-
体外实验Iptakalim (Ipt) hydrochloride has been shown to reverse pulmonary resistance vascular remodeling, inhibit proliferation of pulmonary arterial smooth muscle cells (PASMCs) and airway smooth muscle cells (ASMCs), as well as protect PAECs from pathological stimulation.Iptakalim has an inhibitory effect on [Ca2+]cyt increase and the proliferation of pulmonary arterial SMCs induced by endothelin-1 through activation of KATP channels. Iptakalim (10 μM, 10 min) pretreatment of pulmonary arterial SMCs significantly prevents ransient ncrease of [Ca2+]cyt elicited by endothelin-1.Iptakalim at he concentrations of 0.1, 1, and 10 AM lowered[3H]thymidine incorporation by 19.75±4.60% (n=10), 41.20±9.49% (n=10), and 54.74±10.11% (n=10), respectively, compared with that of cells treated only with endothelin-1.
-
体内实验Iptakalim (10-60 mg/kg) attenuates nicotine-evoked conditioned responding. Iptakalim also attenuates chamber activity in these nicotine test sessions..Iptakalim (60 mg/kg) pretreatment significantly reduced activity (LSD comparisons).. Animal Model:Thirty male Sprague-Dawley rats weighing 275-299 grams.Dosage:0, 10, 30, or 60 mg/kg.Administration:IP, 10 min before the start of a 4-min test session.Result:Decreased chamber activity.Dipper entries following pretreatment with 30 and 60 mg/kg Iptakalim were significantly lower than with 0 (saline) or 10 mg/kg iptakalim pretreatment (Tukey HSD tests).
-
同义词——
-
通路Cell Cycle/DNA Damage
-
靶点Potassium Channel
-
受体Aldose reductase
-
研究领域——
-
适应症——
化学信息
-
CAS Number642407-63-4
-
分子量179.73
-
分子式C9H22ClN
-
纯度>98% (HPLC)
-
溶解度In Vitro:?H2O : 25 mg/mL (139.10 mM)
-
SMILESCl.CC(C)NC(C)(C)C(C)C
-
化学全称——
运输与储存
-
储存条件(-20℃)
-
运输条件With Ice Pack
-
稳定性≥ 2 years
参考文献
1.Simard-Duquesne N, et al. The effects of a new aldose reductase inhibitor (tolrestat) in galactosemic and diabetic rats. Metabolism. 1985 Oct;34(10):885-92.
产品手册
关联产品
-
KCNQ1 activator-1?
2-Piperidinecarboxamide, N-[4-(4-甲氧基苯基)-2-thiazolyl]-1-(苯基磺酰基)- 是一种有效的 KCNQ1 通道激活剂,可用于长 QT 综合征 (LQTS) 研究。
-
Tolbutamide
Tolbutamide 是一种钾通道抑制剂,用于治疗 II 型糖尿病。
-
Agitoxin 2
Potent Shaker K+ channel blocker (Ki = 0.64 nM). Also inhibits Kv1.3, Kv1.6 and Kv1.1 K+ channels (Ki values are 4, 37 and 44 pM respectively).
021-51111890
购物车()
sales@molnova.cn

